Page last updated: 2024-08-22

sodium selenite and Cancer of Prostate

sodium selenite has been researched along with Cancer of Prostate in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's26 (74.29)29.6817
2010's9 (25.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fesenko, EE; Goltyaev, MV; Gorbacheva, OS; Kuznetsova, YP; Novoselov, SV; Varlamova, EG1
Chen, P; Li, N; Liu, Q; Ni, J; Wang, L1
Song, G; Xiang, N; Zhao, R; Zhong, W1
Bhattacharyya, RS; Feldman, D; Husbeck, B; Knox, SJ2
Bosland, MC; Kandaş, NO; Randolph, C1
Berggren, M; Burd, R; Meuillet, EJ; Samira, JL; Sittadjody, S; Song, Z1
Domann, FE; Xiang, N; Zhao, R; Zhong, W2
Alkan, Z; Dawson, K; Hawkes, WC; Richter, BD; Wang, TT1
Guo, Y; Jin, Y; Li, H; Lin, D; Pei, Z1
Ghosh, J; Liroff, J; Nikitin, AY; Sarveswaran, S; Zhou, Z1
Knox, SJ; Ning, S; Tian, J1
Alves, V; Freitas, M; Mota-Pinto, A; Sarmento-Ribeiro, AB1
Anderson, LB; Li, G; Lü, J; Wang, L; Witthuhn, B; Xu, Y; Zhang, J1
de Rosa, V; Diamond, AM; Douki, T; Erkekoğlu, P; Favier, A; Forestier, A; Hincal, F; Rachidi, W1
Bespalov, VG; Chepik, OF; Murazov, IaG; Panchenko, AV1
Ganther, H; Jiang, C; Lü, J; Wang, Z2
Corcoran, NM; Costello, AJ; Najdovska, M1
Goulet, AC; Kagey, J; Meuillet, E; Nelson, MA; Porterfield, B; Prasad Cherukuri, D; Stratton, S1
Oberley, TD; Webber, MM; Yan, T; Zhong, W1
Cho, SD; Dong, Y; Ip, C; Jiang, C; Kang, KS; Lee, YS; Lü, J; Malewicz, B; Young, CY1
Hu, H; Jiang, C; Lü, J; Malewicz, B; Wang, Z1
Lipinski, B1
Husbeck, B; Knox, SJ; Peehl, DM1
Husbeck, B; Knox, SJ; Nonn, L; Peehl, DM1
Daniel, PT; Hu, H; Jiang, C; Li, GX; Lü, J; Schuster, T1
Bosello, V; Bulato, C; Maiorino, M; Ursini, F1
Hu, H; Jiang, C; Li, GX; Lü, J; Schuster, T1
Donkena, KV; Gazi, MH; Gong, A; Young, CY1
Ansford, A; Williams, R1
Xiang, N; Zhao, R; Zhong, W1
Lippman, SM; Menter, DG; Sabichi, AL1
Oberley, TD; Zhong, W1

Reviews

1 review(s) available for sodium selenite and Cancer of Prostate

ArticleYear
Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.
    Journal of cellular biochemistry, 2004, Feb-15, Volume: 91, Issue:3

    Topics: Clinical Trials as Topic; Drug Evaluation, Preclinical; Eligibility Determination; Humans; Male; Models, Biological; Organoselenium Compounds; Prostatic Neoplasms; Selenium; Sodium Selenite; Vitamin E

2004

Other Studies

34 other study(ies) available for sodium selenite and Cancer of Prostate

ArticleYear
Influence of Sodium Selenite on the mRNA Expression of the Mammalian Selenocysteine-Containing Protein Genes in Testicle and Prostate Cancer Cells.
    Doklady. Biochemistry and biophysics, 2018, Volume: 480, Issue:1

    Topics: Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Proteins; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Selenoproteins; Sodium Selenite; Testicular Neoplasms

2018
Comparative proteomics analysis of sodium selenite-induced apoptosis in human prostate cancer cells.
    Metallomics : integrated biometal science, 2013, Volume: 5, Issue:5

    Topics: Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Shape; Cell Survival; Electrophoresis, Gel, Two-Dimensional; Humans; Male; Membrane Potential, Mitochondrial; Mitochondria; Neoplasm Proteins; Prostatic Neoplasms; Proteomics; Reactive Oxygen Species; Reproducibility of Results; Signal Transduction; Sodium Selenite

2013
Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells.
    Carcinogenesis, 2008, Volume: 29, Issue:11

    Topics: Acetylation; Blotting, Western; Cell Line, Tumor; Chromatin Immunoprecipitation; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Glutathione S-Transferase pi; Histones; Humans; Male; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostatic Neoplasms; Sodium Selenite

2008
Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
    International journal of radiation oncology, biology, physics, 2008, Nov-01, Volume: 72, Issue:3

    Topics: Androgens; Animals; Antineoplastic Agents; Biomarkers; Cell Division; Cell Line, Tumor; Female; Humans; Male; Mice; Prostate-Specific Antigen; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sodium Selenite; Transplantation, Heterologous

2008
Differential effects of selenium on benign and malignant prostate epithelial cells: stimulation of LNCaP cell growth by noncytotoxic, low selenite concentrations.
    Nutrition and cancer, 2009, Volume: 61, Issue:2

    Topics: Androgens; Apoptosis; Caspase 3; Cell Division; Cell Line; Cell Line, Tumor; Cell Survival; Enzyme Activation; Epithelial Cells; Humans; Male; Poly(ADP-ribose) Polymerases; Prostatic Hyperplasia; Prostatic Neoplasms; RNA, Messenger; Selenium; Sodium Selenite; Thioredoxin-Disulfide Reductase

2009
Sodium selenite increases the activity of the tumor suppressor protein, PTEN, in DU-145 prostate cancer cells.
    Nutrition and cancer, 2009, Volume: 61, Issue:3

    Topics: Casein Kinase II; Cell Line, Tumor; Glutathione; Humans; Male; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Sodium Selenite; Thioredoxin-Disulfide Reductase; Thioredoxins; Tumor Suppressor Proteins

2009
Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells.
    Nutrition and cancer, 2009, Volume: 61, Issue:3

    Topics: Anticarcinogenic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; G2 Phase; Genistein; Humans; Insulin-Like Growth Factor I; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Sodium Selenite; Tumor Suppressor Protein p53

2009
Selenoprotein W modulates control of cell cycle entry.
    Biological trace element research, 2009, Volume: 131, Issue:3

    Topics: Base Sequence; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; DNA Primers; Female; Humans; Male; Models, Biological; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; RNA Interference; RNA, Messenger; RNA, Small Interfering; Selenium; Selenoprotein W; Sodium Selenite

2009
Sodium selenite inhibits the expression of VEGF, TGFbeta(1) and IL-6 induced by LPS in human PC3 cells via TLR4-NF-(K)B signaling blockage.
    International immunopharmacology, 2010, Volume: 10, Issue:1

    Topics: Active Transport, Cell Nucleus; Cell Line, Tumor; Cell Nucleus; Gene Expression Regulation, Neoplastic; Humans; Immunization; Interleukin-6; Lipopolysaccharides; Male; NF-kappa B; Prostatic Neoplasms; Signal Transduction; Sodium Selenite; Toll-Like Receptor 4; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A

2010
Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer.
    International journal of oncology, 2010, Volume: 36, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sodium Selenite; Transcription, Genetic; Tumor Suppressor Protein p53

2010
Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
    International journal of radiation oncology, biology, physics, 2010, Sep-01, Volume: 78, Issue:1

    Topics: Animals; Cell Line, Tumor; Cell Survival; Colony-Forming Units Assay; Drug Administration Schedule; Drug Screening Assays, Antitumor; Epithelial Cells; Female; Glutathione; Glutathione Disulfide; Humans; Injections, Intraperitoneal; Intestines; Male; Mice; Mice, Inbred C3H; Mice, SCID; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Sodium Selenite; Transplantation, Heterologous; Tumor Burden

2010
Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line.
    Biochemical and biophysical research communications, 2011, May-20, Volume: 408, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Docetaxel; Drug Synergism; Humans; Male; Peroxides; Prostatic Neoplasms; Sodium Selenite; Taxoids

2011
Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.
    Nutrition and cancer, 2011, Volume: 63, Issue:5

    Topics: Animals; Anticarcinogenic Agents; Cysteine; Gene Expression Profiling; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Organoselenium Compounds; Prostate; Prostatic Neoplasms; Protein Biosynthesis; Proteomics; RNA, Messenger; Selenium Compounds; Selenocysteine; Selenomethionine; Sodium Selenite; Xenograft Model Antitumor Assays

2011
Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells.
    Free radical research, 2012, Volume: 46, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Anticarcinogenic Agents; Antioxidants; Cell Line, Tumor; Cell Survival; Deoxyguanosine; DNA Fragmentation; DNA Repair; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Hydrogen Peroxide; Male; Oxidation-Reduction; Oxidative Stress; Prostatic Neoplasms; Selenomethionine; Sodium Selenite; Thioredoxin-Disulfide Reductase; Ultraviolet Rays

2012
[Influence of sodium selenite on carcinogenesis of the prostate and other organs induced by methylnitrosourea and testosterone in rats].
    Voprosy onkologii, 2011, Volume: 57, Issue:4

    Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, Neoplastic; Drinking Water; Lymphoma; Male; Methylnitrosourea; Orchiectomy; Precancerous Conditions; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Rats, Wistar; Sodium Selenite; Testosterone

2011
Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
    Molecular cancer therapeutics, 2002, Volume: 1, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Death; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; DNA Fragmentation; G1 Phase; Humans; Immunoblotting; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Organoselenium Compounds; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Kinases; S Phase; Selenium; Sodium Selenite; Superoxides; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins

2002
Inorganic selenium retards progression of experimental hormone refractory prostate cancer.
    The Journal of urology, 2004, Volume: 171, Issue:2 Pt 1

    Topics: Animals; Cell Line, Tumor; Disease Progression; Hormones; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Prostatic Neoplasms; Sodium Selenite; Time Factors; Treatment Failure

2004
Alteration of cellular phenotype and responses to oxidative stress by manganese superoxide dismutase and a superoxide dismutase mimic in RWPE-2 human prostate adenocarcinoma cells.
    Antioxidants & redox signaling, 2004, Volume: 6, Issue:3

    Topics: Adenocarcinoma; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Complementary; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Humans; Male; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxygen; Phenotype; Plasmids; Prostatic Neoplasms; Rats; Sodium Selenite; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Transfection

2004
Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:5

    Topics: Androgens; Cell Death; Cell Line, Tumor; Humans; Male; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Processing, Post-Translational; Receptors, Androgen; RNA, Messenger; Selenomethionine; Sodium Selenite; Time Factors; Transcription, Genetic

2004
Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:7

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Benzothiazoles; Caspase Inhibitors; Caspases; Cell Line, Tumor; Enzyme Activation; Humans; Male; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Serine; Sodium Selenite; Thiazoles; Toluene; Tumor Suppressor Protein p53

2004
Re: Science peels the onion of selenium effects on prostate carcinogenesis.
    Journal of the National Cancer Institute, 2004, Nov-03, Volume: 96, Issue:21

    Topics: Anticarcinogenic Agents; Antioxidants; Humans; Male; Oxidation-Reduction; Prostatic Neoplasms; Selenic Acid; Selenium Compounds; Sodium Selenite

2004
Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing.
    Free radical biology & medicine, 2005, Jan-01, Volume: 38, Issue:1

    Topics: Apoptosis; bcl-2-Associated X Protein; Gamma Rays; Glutathione; Humans; Male; Oxidation-Reduction; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Sodium Selenite; Tumor Cells, Cultured

2005
Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells.
    The Prostate, 2006, Feb-01, Volume: 66, Issue:2

    Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Proliferation; Cells, Cultured; Epithelium; Glutathione; Humans; Immunohistochemistry; Male; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sensitivity and Specificity; Sodium Selenite; Superoxide Dismutase; Tumor Cells, Cultured

2006
Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells.
    Cancer research, 2006, Feb-15, Volume: 66, Issue:4

    Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Humans; Male; Metalloporphyrins; Mitochondria; Prostatic Neoplasms; Protein Modification, Translational; Sodium Selenite; Superoxides; Tumor Suppressor Protein p53

2006
Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Caspases; Cytochromes c; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Humans; Male; Membrane Glycoproteins; Membrane Potentials; Mitochondrial Membranes; Prostatic Neoplasms; Reactive Oxygen Species; Sodium Selenite; Superoxides; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53

2006
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:8

    Topics: Acetylcysteine; Androgen Receptor Antagonists; Dose-Response Relationship, Drug; Down-Regulation; Glutathione; Humans; Male; Metalloporphyrins; Metribolone; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Steroid; Signal Transduction; Sodium Selenite; Sp1 Transcription Factor; Superoxides; Tumor Cells, Cultured

2006
Effect of mercury on selenium utilization and selenoperoxidase activity in LNCaP cells.
    Free radical biology & medicine, 2007, Jan-01, Volume: 42, Issue:1

    Topics: Humans; Hydrogen Peroxide; Male; Mercury; Prostatic Neoplasms; Selenium; Selenocysteine; Selenomethionine; Selenoproteins; Sodium Selenite; Tumor Cells, Cultured

2007
Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
    International journal of cancer, 2007, May-01, Volume: 120, Issue:9

    Topics: Acetylcysteine; Androgens; Antioxidants; Apoptosis; Caspases; Cell Line, Tumor; DNA Breaks; Humans; Male; Organoselenium Compounds; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Sodium Selenite; Tumor Suppressor Protein p53

2007
Sodium selenite inhibits interleukin-6-mediated androgen receptor activation in prostate cancer cells via upregulation of c-Jun.
    Clinica chimica acta; international journal of clinical chemistry, 2007, May-01, Volume: 380, Issue:1-2

    Topics: Androgens; Blotting, Western; Cell Proliferation; Genes, Reporter; Humans; Interleukin-6; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-jun; Receptors, Androgen; Receptors, Interleukin-6; Sodium Selenite; STAT3 Transcription Factor; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation

2007
Acute selenium toxicity: Australia's second fatality.
    Pathology, 2007, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Aged; Australia; Humans; Internet; Male; Prostatic Neoplasms; Sodium Selenite

2007
Sodium selenite induces apoptosis by generation of superoxide via the mitochondrial-dependent pathway in human prostate cancer cells.
    Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:2

    Topics: Adenoviridae; Apoptosis; Catalase; Cell Line, Tumor; Cell Survival; Cytosol; Dose-Response Relationship, Drug; Glutathione Peroxidase; Humans; Male; Membrane Potential, Mitochondrial; Mitochondria; Prostatic Neoplasms; Sodium Selenite; Superoxide Dismutase; Superoxides; Time Factors

2009
Selenium effects on prostate cell growth.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2000, Volume: 9, Issue:11

    Topics: Apoptosis; Cell Cycle; Cell Transformation, Neoplastic; DNA Damage; Dose-Response Relationship, Drug; Humans; Male; Prostatic Neoplasms; Selenium; Sodium Selenite; Tumor Cells, Cultured

2000
Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells.
    Cancer research, 2001, Apr-01, Volume: 61, Issue:7

    Topics: Anoikis; Caspase Inhibitors; Caspases; Cysteine Proteinase Inhibitors; Cytochrome c Group; DNA Fragmentation; Enzyme Activation; Humans; Isoenzymes; Male; Mitochondria; Nucleosomes; Organoselenium Compounds; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Sodium Selenite; Substrate Specificity; Tumor Cells, Cultured

2001
Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line.
    Cancer research, 2001, Oct-01, Volume: 61, Issue:19

    Topics: Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Glutathione; Glutathione Disulfide; Glutathione Peroxidase; Growth Inhibitors; Humans; Male; Mitochondria; Oxidation-Reduction; Prostatic Neoplasms; Sodium Selenite; Superoxide Dismutase; Tumor Cells, Cultured; Tumor Suppressor Proteins

2001